![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
CASE REPORT
Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2022 March;181(3):183-6
DOI: 10.23736/S0393-3660.20.04466-6
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
COVID-19 and ST-segment elevation: how far should we go?
Cristina P. CORREIA ✉, Inês A. NEVES, Pedro FERREIRA, Jorge OLIVEIRA
Department of Internal Medicine, São João Hospital Center, Porto, Portugal
Cardiovascular diseases have been associated with higher risk of COVID infection, severity of its clinical presentation and a significant increase in overall mortality. We reported the case of a 77-year-old patient who recovered from a severe acute respiratory syndrome-coronavirus-2(SARS-CoV-2) after a complex treatment approach that included mechanical ventilation for 26 days and high flow nasal cannula (HFNC) therapy for 17 days. Relevant ST-segment elevations in inferior leads were documented, with mild troponin elevation and without relevant ultrasound alterations. A Cardiac magnetic resonance imaging was then requested. We emphasize the relevance of postponing invasive tests until significant recovery. The real incidence of acute myocardial injury related to COVID- 19 requires a standardized definition beyond surveillance of future complications.
KEY WORDS: ST elevation myocardial infarction; SARS-CoV-2; COVID-19